Results 101 to 110 of about 60,346 (233)

Lamivudine plasma levels in chronic hepatitis B patients [PDF]

open access: yes, 2003
Lamivudine has recently been registered for the treatment of chronic hepatitis B patients. The main therapeutic outcome in the studies on which the registration was based was a drop of HBV DNA below 10(7) genome equivalents/ml, the ...
Dijk, L.J. (Laurens) van   +5 more
core   +1 more source

Neurological efficacy of stavudine, zidovudine, and lamivudine [PDF]

open access: bronze, 1998
Magnus Gisslén   +2 more
openalex   +1 more source

HIV positive patient with GBS-like syndrome [PDF]

open access: yes, 2017
Introduction. Guillain–Barré Syndrome (GBS) is an acute demyelinating polyneuropathy which can occur post-infection. Criteria of diagnosis of GBS include areflexia with progressive bilateral weakness in arms and legs.
Black, Heather   +3 more
core   +1 more source

Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients [PDF]

open access: hybrid, 2011
Young Kul Jung   +10 more
openalex   +1 more source

Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon [PDF]

open access: yes, 2008
OBJECTIVES: To compare adherence to antiretroviral therapy using drug level monitoring and self-report and to explore the relation between these 2 methods and viral load measurements.
Alexandra Calmy   +29 more
core   +3 more sources

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children

open access: yesJournal of Virus Eradication, 2015
Background: Abacavir and lamivudine are approved for once-daily use in HIV-infected adults Limited pharmacokinetic (PK) data for abacavir and lamivudine in children are available.
Torsak Bunupuradah   +9 more
doaj   +1 more source

Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study. [PDF]

open access: yes, 2017
BackgroundThere is ongoing controversy regarding abacavir use in the treatment of HIV infection and the risk of subsequent development of cardiovascular disease.
Baxi, Sanjiv M   +3 more
core   +3 more sources

Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen [PDF]

open access: bronze, 2007
Mona Loutfy   +18 more
openalex   +1 more source

Lamivudine for the Treatment of Membranous Glomerulopathy Secondary to Chronic Hepatitis B Infection

open access: yesCanadian Journal of Gastroenterology, 2005
Membranous glomerulopathy is a well-recognized extrahepatic manifestation of chronic hepatitis B virus (HBV) infection. The authors report two cases of HBV-related nephrotic syndrome treated with lamivudine.
SI Gan   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy